Joseph K. Belanoff, Chief Executive Officer at CORCEPT THERAPEUTICS INC (CORT), sold 615 shares at $73.69 ($45K) on 2025-07-17, disclosed to the SEC on 2025-07-21.
Scheduled sale ($45k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CORT | SELL | 2026-03-27 | $2.6M | — | Filing → |
| CORT | SELL | 2025-12-03 | $3.2M | — | Filing → |
| CORT | SELL | 2025-11-05 | $4.9M | — | Filing → |